1、 IKARI A, TAGA S, WATANABE R, et al. Clathrin-dependent endocytosis of claudin-2 by DFYSP peptide causes lysosomal damage in lung adenocarcinoma A549 cells[J].Biochimica et Biophysica Acta (BBA)-Biomembranes, 2015, 1848(10): 2326-2336. IKARI A, TAGA S, WATANABE R, et al. Clathrin-dependent endocytosis of claudin-2 by DFYSP peptide causes lysosomal damage in lung adenocarcinoma A549 cells[J].Biochimica et Biophysica Acta (BBA)-Biomembranes, 2015, 1848(10): 2326-2336.
2、 ZOIS CE, KOUKOURAKIS MI. Radiation-induced autophagy in normal and cancer cells: towards novel cytoprotection and radio-sensitization policies[J]. Autophagy, 2009,5(4):442-450. ZOIS CE, KOUKOURAKIS MI. Radiation-induced autophagy in normal and cancer cells: towards novel cytoprotection and radio-sensitization policies[J]. Autophagy, 2009,5(4):442-450.
3、 GUGLIELMELLI T, GIUGLIANO E, BRUNETTO V, et al. mTOR pathway activation in multiple myeloma cell lines and primary tumour cells: pomalidomide enhances cytoplasmic-nuclear shuttling of mTOR protein[J].Oncoscience, 2015, 2(4): 382. GUGLIELMELLI T, GIUGLIANO E, BRUNETTO V, et al. mTOR pathway activation in multiple myeloma cell lines and primary tumour cells: pomalidomide enhances cytoplasmic-nuclear shuttling of mTOR protein[J].Oncoscience, 2015, 2(4): 382.
4、 DI CORATO R, BéALLE G, KOLOSNJAJ-TABI J, et al. Combining magnetic hyperthermia and photodynamic therapy for tumor ablation with photoresponsive magnetic liposomes[J].ACS nano, 2015, 9(3): 2904-2916. DI CORATO R, BéALLE G, KOLOSNJAJ-TABI J, et al. Combining magnetic hyperthermia and photodynamic therapy for tumor ablation with photoresponsive magnetic liposomes[J].ACS nano, 2015, 9(3): 2904-2916.
5、 HIRATA Y, YAMAMOTO H, ATTA MS,et al. Chloroquine inhibits glutamate-induced death of a neuronal cell line by reducing reactive oxygen species through sigma-1 receptor[J].J Neurochem,2011,119(4):839-847. HIRATA Y, YAMAMOTO H, ATTA MS,et al. Chloroquine inhibits glutamate-induced death of a neuronal cell line by reducing reactive oxygen species through sigma-1 receptor[J].J Neurochem,2011,119(4):839-847.
6、 SOLOMON VR, LEE H. Chloroquine and its analogs: a new promise of an old drug for effective and safe cancer therapies[J].Eur J Pharmacol,2009,25;625(1-3):220-233. SOLOMON VR, LEE H. Chloroquine and its analogs: a new promise of an old drug for effective and safe cancer therapies[J].Eur J Pharmacol,2009,25;625(1-3):220-233.
7、 成军. 现代细胞自噬分子生物学[M]. 北京: 科学出版社, 2011. 成军. 现代细胞自噬分子生物学[M]. 北京: 科学出版社, 2011.
8、 GALLO M, MICHELON F, CASTIGLIONE A, et al. Sorafenib treatment of radioiodine- refractory advanced thyroid cancer in daily clinical practice: a cohort study from a single center[J].Endocrine, 2015, 49(3): 726-734. GALLO M, MICHELON F, CASTIGLIONE A, et al. Sorafenib treatment of radioiodine- refractory advanced thyroid cancer in daily clinical practice: a cohort study from a single center[J].Endocrine, 2015, 49(3): 726-734.
9、 南岩东, 姜华, 金发光, 等. S100A6 基因干扰对 A549 肺腺癌细胞生物学行为的影响[J].国际肿瘤学杂志, 2016, 43: 161-166. 南岩东, 姜华, 金发光, 等. S100A6 基因干扰对 A549 肺腺癌细胞生物学行为的影响[J].国际肿瘤学杂志, 2016, 43: 161-166.
10、 MORTENSEN DS, PERRIN-NINKOVIC SM, SHEVLIN G, et al. Optimization of a series of triazole containing mammalian target of rapamycin (mTOR) kinase inhibitors and the discovery of CC-115[J].Journal of medicinal chemistry, 2015, 58(14): 5599-5608. MORTENSEN DS, PERRIN-NINKOVIC SM, SHEVLIN G, et al. Optimization of a series of triazole containing mammalian target of rapamycin (mTOR) kinase inhibitors and the discovery of CC-115[J].Journal of medicinal chemistry, 2015, 58(14): 5599-5608.
11、 PERRI F, PEZZULLO L, CHIOFALO MG, et al. Targeted therapy: A new hope for thyroid carcinomas[J].Critical reviews in oncology/hematology, 2015, 94(1): 55-63. PERRI F, PEZZULLO L, CHIOFALO MG, et al. Targeted therapy: A new hope for thyroid carcinomas[J].Critical reviews in oncology/hematology, 2015, 94(1): 55-63.
12、 LEVERSON JD, ZHANG H, CHEN J, et al. Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax)[J].Cell death & disease, 2015, 6(1): e1590. LEVERSON JD, ZHANG H, CHEN J, et al. Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax)[J].Cell death & disease, 2015, 6(1): e1590.
13、 CHIARINI F, EVANGELISTI C, MCCUBREY JA, et al. Current treatment strategies for inhibiting mTOR in cancer[J]. Trends in pharmacological sciences,2015,36(2): 124-135. CHIARINI F, EVANGELISTI C, MCCUBREY JA, et al. Current treatment strategies for inhibiting mTOR in cancer[J]. Trends in pharmacological sciences,2015,36(2): 124-135.
